
Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 6.07% | |
| Drug Manufacturers - General | 42.22% | 18.55% | |
| Biotechnology | 12.64% | 5.61% | |
| Medical Devices | 11.53% | 1.05% | |
| Diagnostics & Research | 9.36% | -8.14% | |
| Healthcare Plans | 7.47% | -7.89% | |
| Medical Instruments & Supplies | 6.54% | -4.48% | |
| Medical Distribution | 3.38% | 14.80% | |
| Medical Care Facilities | 3.16% | 10.49% | |
| Drug Manufacturers - Specialty & Generic | 2.54% | 1.58% | |
| Health Information Services | 1.15% | -37.03% | |
| Pharmaceutical Retailers | 0.00% | -16.16% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 1,017.97 | 1,214.34 | 13.12% | 960.31B | -3.23% | -5.28% | Buy | |
| 248.56 | 233.13 | 8.19% | 599.004B | +0.05% | +20.11% | Buy | |
| 234.26 | 248.69 | 5.66% | 414.211B | +0.94% | +2.53% | Buy | |
| 121.41 | 127.21 | 4.10% | 300.173B | -1.95% | +15.34% | Buy | |
| 294.93 | 364.62 | 3.65% | 267.159B | +0.57% | -10.66% | Buy | |
| 385.70 | 350.04 | 2.84% | 207.918B | -0.58% | +17.84% | Buy | |
| 114.12 | 133.39 | 2.71% | 198.621B | -1.92% | -8.92% | Buy | |
| 508.58 | 666.46 | 2.61% | 191.078B | -2.40% | -12.23% | Strong Buy | |
| 150.03 | 156.59 | 2.55% | 186.25B | +0.73% | +22.23% | Buy | |
| 496.25 | 609.82 | 2.41% | 176.233B | -1.44% | -12.38% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 158.53 | 40.98B | 0.08% | +2.41% | |
| 292.69 | 19.812B | 0.09% | +1.68% | |
| 173.92 | 8.534B | 0.44% | +3.05% | |
| 126.55 | 8.336B | 0.35% | +3.79% | |
| 100.28 | 4.621B | 0.40% | +2.96% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 208.19 | 39.263B | 0.32% | +1.77% | |
| 87.78 | 39.263B | 0.32% | +1.77% | |
| 146.47 | 19.812B | 0.09% | +1.76% | |
| 134.88 | 15.226B | 0.00% | +1.25% | |
| 11.24 | 15.226B | 0.00% | +1.13% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
RatingPrice TargetDaily – Vickers Top Buyers & Sellers for 03/02/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Insider Picks for 03/02/2026
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Weekly Stock List
Earnings season is winding down and the most-recent reports from S&P 500 companies have given us a chance to look at trends. For one, a number of companies have raised guidance - an indictor we monitor. We view management's ability to raise guidance as a likely catalyst for market-beating returns in the quarters ahead. (We note that it's even harder for companies to raise guidance during uncertain economic times.) The current list of companies that did raise guidance is not as hefty as normal, likely because many companies are cautiously initiating guidance for the new year. Here is a partial list of companies in our Fundamental Universe of Coverage that increased guidance during the recent reporting season.


















